cfDNA test
- Analysis of no call results of NIPTS (Panorama)
- Association between fetal fraction on cell-free DNA testing and first trimester markers for pre-eclampsia
- Can total cell-free DNA in maternal plasma or serum be used to predict preeclampsia? A systematic review
- Cell-free DNA and contingent screening: our experience
- Cell-free DNA: positive predictive value for Turner syndrome is dependent on nuchal translucency measurement
- Cell-free fetal DNA testing in singleton in-vitro fertilisation conceptions
- CfDNA testing for Klinefelter syndrome
- Development of a non-invasive prenatal screening for fetal aneuploidies using next-generation sequencing
- Expanded targeted exome sequencing in fetuses with ultrasound abnormalities
- Fetal DNA in maternal blood in prenatal screening of aneuploidies: Preliminary study for the adoption of the test
- Fetal fraction of cell-free DNA and placental function in IVF/ICSI and spontaneous pregnancy
- Genetic analysis for a prenatal diagnosis of complex chromosomal rearrangement
- Haplotype-based noninvasive prenatal testing for duchenne muscular dystrophy: a pilot study in South China
- High resolution chromosomal microarray analysis across all indications in prenatal diagnosis: is more better?
- Impact of cell free DNA analysis on invasive testing in a tertiary referral Fetal Medicine Centre
- Isochromosome 21q is overrepresented among false-negative cell-free DNA results involving Down syndrome
- NIPT is it a key of prenatal diagnosis or is a complement?
- Non-invasive prenatal test for FGFR3-related skeletal dysplasia based on next-generation sequencing and cfDNA
- Non-invasive prenatal testing as a primary screening method for common foetal aneuploidies
- Optimal non-invasive diagnosis of achondroplasia combining ultrasonography and cfDNA analysis
- Statistical and preliminary cost-effectiveness analysis of noninvasive prenatal screening of 309, 996 cases
- The misuse of cell-free DNA by obstetricians in cases of abnormal ultrasound findings
- Use of target sequencing in noninvasive prenatal testing for beta thalassemia